Microassays for Enzyme Activity

Information

  • Research Project
  • 6779114
  • ApplicationId
    6779114
  • Core Project Number
    R44DK059055
  • Full Project Number
    5R44DK059055-03
  • Serial Number
    59055
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/15/2001 - 24 years ago
  • Project End Date
    6/30/2005 - 20 years ago
  • Program Officer Name
    SECHI, SALVATORE
  • Budget Start Date
    7/1/2004 - 21 years ago
  • Budget End Date
    6/30/2005 - 20 years ago
  • Fiscal Year
    2004
  • Support Year
    3
  • Suffix
  • Award Notice Date
    6/30/2004 - 21 years ago
Organizations

Microassays for Enzyme Activity

DESCRIPTION (provided by applicant): Longitudinal metabolic and physiological studies in small animal models of disease will greatly benefit from new methods of easy, rapid enzyme assay in very small sample volumes (sub-microliter). Phase 1 demonstrated the feasibility of adapting silicon microsampling and assay devices, originally developed for blood glucose monitoring, to enzyme activity measurement. A novel technique, "Diffusive Enzyme Activity Measurement" was developed. An electrochemical redox-mediated serum cholinesterase assay was the example, requiring no on-chip biologicals (providing a potentially long shelf-life). Silicon microchips with novel diffusional microfluidics were designed and fabricated. These disposable microchips have integrated silicon microneedles capable of penetrating the skin and taking a blood sample painlessly and reliably. In Phase II, this technique will be generalized to other enzymes. A computer simulation model will be used, experimental work will develop assays for the families of cholinesterases and lactate oxidizing enzymes, and a prototype readout instrument will be built. The enzymes chosen for Phase ll kinetic constants are covering many orders of magnitude, to probe the range of applicability of this new analytical method. Potential commercial applications include enzyme activity measurements on sub-microliter liquid samples, such as blood drawn from experimental animals (or humans), tissue extract specimens, purified enzymes, and drug discovery research and development.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R44
  • Administering IC
    DK
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    354519
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
    NIDDK:354519\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    KUMETRIX, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    UNION CITY
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94587
  • Organization District
    UNITED STATES